Exponent, Inc. Logo

Exponent, Inc.

EXPO

(2.8)
Stock Price

90,67 USD

14.96% ROA

27.73% ROE

54.68x PER

Market Cap.

5.689.955.312,00 USD

19.15% DER

0.98% Yield

19.52% NPM

Exponent, Inc. Stock Analysis

Exponent, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Exponent, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (29.69%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (8%), which means it has a small amount of debt compared to the ownership it holds

4 Dividend Growth

The company has demonstrated exceptional dividend growth over the past five years, consistently increasing payouts to shareholders year after year.

5 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

6 Buffet Intrinsic Value

The company's stock seems undervalued (433) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (11.18x) suggests it's overvalued, potentially making it an expensive investment.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

10 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

Exponent, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Exponent, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Exponent, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Exponent, Inc. Revenue
Year Revenue Growth
1989 59.900.000
1990 69.600.000 13.94%
1991 70.300.000 1%
1992 65.400.000 -7.49%
1993 35.800.000 -82.68%
1994 58.100.000 38.38%
1995 58.400.000 0.51%
1996 58.700.000 0.51%
1997 73.500.000 20.14%
1998 85.500.000 14.04%
1999 93.271.000 8.33%
2000 101.598.000 8.2%
2001 104.497.000 2.77%
2002 126.055.000 17.1%
2003 139.676.000 9.75%
2004 151.509.000 7.81%
2005 155.196.000 2.38%
2006 168.496.000 7.89%
2007 205.148.000 17.87%
2008 228.838.000 10.35%
2009 227.882.000 -0.42%
2010 248.753.000 8.39%
2011 272.446.000 8.7%
2012 292.653.000 6.9%
2013 296.168.000 1.19%
2014 304.704.000 2.8%
2015 312.832.000 2.6%
2016 315.076.000 0.71%
2017 347.799.000 9.41%
2018 379.523.000 8.36%
2019 417.199.000 9.03%
2020 399.900.000 -4.33%
2021 466.269.000 14.23%
2022 513.293.000 9.16%
2023 533.344.000 3.76%
2023 536.765.999 0.64%
2024 562.144.000 4.51%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Exponent, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Exponent, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 43.300.000 100%
1997 53.000.000 18.3%
1998 64.000.000 17.19%
1999 69.009.000 7.26%
2000 74.000.000 6.74%
2001 77.500.000 4.52%
2002 83.800.000 7.52%
2003 91.100.000 8.01%
2004 100.593.000 9.44%
2005 103.900.000 3.18%
2006 116.700.000 10.97%
2007 131.500.000 11.25%
2008 146.900.000 10.48%
2009 173.280.000 15.22%
2010 12.364.000 -1301.49%
2011 170.000.000 92.73%
2012 185.368.000 8.29%
2013 198.798.000 6.76%
2014 199.375.000 0.29%
2015 199.797.000 0.21%
2016 208.889.000 4.35%
2017 228.069.000 8.41%
2018 232.584.000 1.94%
2019 272.717.000 14.72%
2020 262.929.000 -3.72%
2021 293.329.000 10.36%
2022 287.895.000 -1.89%
2023 320.116.000 10.07%
2023 344.326.000 7.03%
2024 342.020.000 -0.67%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Exponent, Inc. EBITDA
Year EBITDA Growth
1989 12.800.000
1990 15.800.000 18.99%
1991 12.100.000 -30.58%
1992 10.100.000 -19.8%
1993 -1.800.000 661.11%
1994 3.500.000 151.43%
1995 4.100.000 14.63%
1996 5.100.000 19.61%
1997 7.900.000 35.44%
1998 6.900.000 -14.49%
1999 10.451.000 33.98%
2000 13.059.000 19.97%
2001 13.339.000 2.1%
2002 16.738.000 20.31%
2003 19.610.000 14.65%
2004 22.804.000 14.01%
2005 23.819.000 4.26%
2006 23.201.000 -2.66%
2007 32.870.000 29.42%
2008 36.657.000 10.33%
2009 30.117.000 -21.72%
2010 39.972.000 24.65%
2011 52.337.000 23.63%
2012 57.620.000 9.17%
2013 55.946.000 -2.99%
2014 63.549.000 11.96%
2015 68.933.000 7.81%
2016 61.911.000 -11.34%
2017 72.051.000 14.07%
2018 91.456.000 21.22%
2019 85.111.000 -7.45%
2020 83.249.000 -2.24%
2021 108.927.000 23.57%
2022 140.842.000 22.66%
2023 135.732.000 -3.76%
2023 120.238.000 -12.89%
2024 152.920.000 21.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Exponent, Inc. Gross Profit
Year Gross Profit Growth
1989 49.900.000
1990 24.700.000 -102.02%
1991 23.500.000 -5.11%
1992 22.500.000 -4.44%
1993 7.600.000 -196.05%
1994 15.000.000 49.33%
1995 15.700.000 4.46%
1996 14.800.000 -6.08%
1997 17.100.000 13.45%
1998 17.600.000 2.84%
1999 81.408.000 78.38%
2000 89.126.000 8.66%
2001 87.135.000 -2.28%
2002 108.438.000 19.65%
2003 108.046.000 -0.36%
2004 119.917.000 9.9%
2005 124.243.000 3.48%
2006 136.856.000 9.22%
2007 161.477.000 15.25%
2008 72.725.000 -122.04%
2009 65.607.000 -10.85%
2010 77.018.000 14.82%
2011 89.814.000 14.25%
2012 266.562.000 66.31%
2013 280.043.000 4.81%
2014 289.209.000 3.17%
2015 295.705.000 2.2%
2016 299.197.000 1.17%
2017 329.664.000 9.24%
2018 354.639.000 7.04%
2019 391.390.000 9.39%
2020 96.137.000 -307.12%
2021 433.675.000 77.83%
2022 478.210.000 9.31%
2023 489.356.000 2.28%
2023 135.761.999 -260.45%
2024 167.132.000 18.77%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Exponent, Inc. Net Profit
Year Net Profit Growth
1989 5.100.000
1990 6.400.000 20.31%
1991 4.500.000 -42.22%
1992 2.600.000 -73.08%
1993 -3.300.000 178.79%
1994 1.100.000 400%
1995 2.000.000 45%
1996 -400.000 600%
1997 4.300.000 109.3%
1998 4.100.000 -4.88%
1999 5.188.000 20.97%
2000 7.782.000 33.33%
2001 6.122.000 -27.12%
2002 7.924.000 22.74%
2003 10.166.000 22.05%
2004 12.040.000 15.56%
2005 14.186.000 15.13%
2006 14.194.000 0.06%
2007 20.341.000 30.22%
2008 23.160.000 12.17%
2009 22.127.000 -4.67%
2010 27.521.000 19.6%
2011 32.695.000 15.83%
2012 37.225.000 12.17%
2013 38.640.000 3.66%
2014 40.701.000 5.06%
2015 43.599.000 6.65%
2016 47.480.000 8.17%
2017 41.305.000 -14.95%
2018 72.254.000 42.83%
2019 82.460.000 12.38%
2020 82.552.000 0.11%
2021 101.202.000 18.43%
2022 102.330.000 1.1%
2023 98.152.000 -4.26%
2023 100.339.000 2.18%
2024 116.908.000 14.17%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Exponent, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 100%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 2 0%
2023 2 0%
2024 2 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Exponent, Inc. Free Cashflow
Year Free Cashflow Growth
1989 -9.700.000
1990 3.700.000 362.16%
1991 -1.600.000 331.25%
1992 2.000.000 180%
1993 6.000.000 66.67%
1994 1.800.000 -233.33%
1995 6.200.000 70.97%
1996 1.400.000 -342.86%
1997 -600.000 333.33%
1998 -4.600.000 86.96%
1999 5.657.000 181.32%
2000 12.360.000 54.23%
2001 2.576.000 -379.81%
2002 14.129.000 81.77%
2003 19.347.000 26.97%
2004 13.422.000 -44.14%
2005 10.800.000 -24.28%
2006 16.377.000 34.05%
2007 23.273.000 29.63%
2008 30.722.000 24.25%
2009 24.799.000 -23.88%
2010 33.577.000 26.14%
2011 42.761.000 21.48%
2012 43.563.000 1.84%
2013 55.566.000 21.6%
2014 43.305.000 -28.31%
2015 55.110.000 21.42%
2016 52.553.000 -4.87%
2017 63.113.000 16.73%
2018 74.890.000 15.73%
2019 85.021.000 11.92%
2020 98.325.000 13.53%
2021 117.742.000 16.49%
2022 81.764.000 -44%
2023 110.996.000 26.34%
2023 4.891.000 -2169.39%
2024 47.193.000 89.64%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Exponent, Inc. Operating Cashflow
Year Operating Cashflow Growth
1989 9.100.000
1990 9.700.000 6.19%
1991 4.000.000 -142.5%
1992 5.100.000 21.57%
1993 7.100.000 28.17%
1994 3.000.000 -136.67%
1995 7.600.000 60.53%
1996 4.400.000 -72.73%
1997 3.600.000 -22.22%
1998 1.200.000 -200%
1999 10.628.000 88.71%
2000 21.051.000 49.51%
2001 4.768.000 -341.51%
2002 16.266.000 70.69%
2003 21.664.000 24.92%
2004 16.038.000 -35.08%
2005 13.815.000 -16.09%
2006 19.582.000 29.45%
2007 26.950.000 27.34%
2008 36.368.000 25.9%
2009 26.816.000 -35.62%
2010 36.052.000 25.62%
2011 46.596.000 22.63%
2012 48.505.000 3.94%
2013 61.792.000 21.5%
2014 48.252.000 -28.06%
2015 60.489.000 20.23%
2016 66.946.000 9.65%
2017 67.838.000 1.31%
2018 91.188.000 25.61%
2019 108.059.000 15.61%
2020 103.312.000 -4.59%
2021 124.568.000 17.06%
2022 93.807.000 -32.79%
2023 127.352.000 26.34%
2023 4.891.000 -2503.8%
2024 48.339.000 89.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Exponent, Inc. Capital Expenditure
Year Capital Expenditure Growth
1989 18.800.000
1990 6.000.000 -213.33%
1991 5.600.000 -7.14%
1992 3.100.000 -80.65%
1993 1.100.000 -181.82%
1994 1.200.000 8.33%
1995 1.400.000 14.29%
1996 3.000.000 53.33%
1997 4.200.000 28.57%
1998 5.800.000 27.59%
1999 4.971.000 -16.68%
2000 8.691.000 42.8%
2001 2.192.000 -296.49%
2002 2.137.000 -2.57%
2003 2.317.000 7.77%
2004 2.616.000 11.43%
2005 3.015.000 13.23%
2006 3.205.000 5.93%
2007 3.677.000 12.84%
2008 5.646.000 34.87%
2009 2.017.000 -179.92%
2010 2.475.000 18.51%
2011 3.835.000 35.46%
2012 4.942.000 22.4%
2013 6.226.000 20.62%
2014 4.947.000 -25.85%
2015 5.379.000 8.03%
2016 14.393.000 62.63%
2017 4.725.000 -204.61%
2018 16.298.000 71.01%
2019 23.038.000 29.26%
2020 4.987.000 -361.96%
2021 6.826.000 26.94%
2022 12.043.000 43.32%
2023 16.356.000 26.37%
2023 0 0%
2024 1.146.000 100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Exponent, Inc. Equity
Year Equity Growth
1989 19.300.000
1990 47.900.000 59.71%
1991 52.400.000 8.59%
1992 54.700.000 4.2%
1993 50.500.000 -8.32%
1994 46.100.000 -9.54%
1995 48.400.000 4.75%
1996 49.300.000 1.83%
1997 56.700.000 13.05%
1998 58.300.000 2.74%
1999 60.148.000 3.07%
2000 65.337.000 7.94%
2001 70.531.000 7.36%
2002 83.786.000 15.82%
2003 95.201.000 11.99%
2004 116.984.000 18.62%
2005 133.200.000 12.17%
2006 124.305.000 -7.16%
2007 131.919.000 5.77%
2008 128.094.000 -2.99%
2009 150.071.000 14.64%
2010 183.800.000 18.35%
2011 186.715.000 1.56%
2012 216.429.000 13.73%
2013 235.059.000 7.93%
2014 244.288.000 3.78%
2015 262.804.000 7.05%
2016 273.346.000 3.86%
2017 289.088.000 5.45%
2018 313.909.000 7.91%
2019 350.251.000 10.38%
2020 361.498.000 3.11%
2021 417.065.000 13.32%
2022 320.752.000 -30.03%
2023 356.085.000 9.92%
2023 353.635.000 -0.69%
2024 393.213.000 10.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Exponent, Inc. Assets
Year Assets Growth
1989 58.300.000
1990 83.300.000 30.01%
1991 84.900.000 1.88%
1992 89.200.000 4.82%
1993 83.300.000 -7.08%
1994 75.000.000 -11.07%
1995 77.700.000 3.47%
1996 80.600.000 3.6%
1997 88.300.000 8.72%
1998 87.000.000 -1.49%
1999 80.452.000 -8.14%
2000 85.626.000 6.04%
2001 91.034.000 5.94%
2002 107.216.000 15.09%
2003 121.842.000 12%
2004 144.081.000 15.44%
2005 164.241.000 12.27%
2006 161.216.000 -1.88%
2007 182.391.000 11.61%
2008 183.090.000 0.38%
2009 206.481.000 11.33%
2010 258.892.000 20.24%
2011 268.788.000 3.68%
2012 315.417.000 14.78%
2013 341.861.000 7.74%
2014 365.299.000 6.42%
2015 387.507.000 5.73%
2016 403.744.000 4.02%
2017 439.589.000 8.15%
2018 468.936.000 6.26%
2019 563.411.000 16.77%
2020 580.096.000 2.88%
2021 683.739.000 15.16%
2022 586.662.000 -16.55%
2023 662.321.000 11.42%
2023 602.462.000 -9.94%
2024 709.177.000 15.05%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Exponent, Inc. Liabilities
Year Liabilities Growth
1989 39.000.000
1990 35.400.000 -10.17%
1991 32.500.000 -8.92%
1992 34.500.000 5.8%
1993 32.800.000 -5.18%
1994 28.900.000 -13.49%
1995 29.300.000 1.37%
1996 31.300.000 6.39%
1997 31.600.000 0.95%
1998 28.700.000 -10.1%
1999 20.304.000 -41.35%
2000 20.289.000 -0.07%
2001 20.503.000 1.04%
2002 23.430.000 12.49%
2003 26.641.000 12.05%
2004 27.097.000 1.68%
2005 31.041.000 12.71%
2006 36.911.000 15.9%
2007 50.472.000 26.87%
2008 54.996.000 8.23%
2009 56.410.000 2.51%
2010 75.092.000 24.88%
2011 82.073.000 8.51%
2012 98.988.000 17.09%
2013 106.802.000 7.32%
2014 121.011.000 11.74%
2015 124.703.000 2.96%
2016 130.398.000 4.37%
2017 150.501.000 13.36%
2018 155.027.000 2.92%
2019 213.160.000 27.27%
2020 218.598.000 2.49%
2021 266.674.000 18.03%
2022 265.910.000 -0.29%
2023 306.236.000 13.17%
2023 248.827.000 -23.07%
2024 315.964.000 21.25%

Exponent, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
10.6
Net Income per Share
2.05
Price to Earning Ratio
54.68x
Price To Sales Ratio
10.5x
POCF Ratio
37.64
PFCF Ratio
39.4
Price to Book Ratio
14.58
EV to Sales
10.27
EV Over EBITDA
44.15
EV to Operating CashFlow
36.52
EV to FreeCashFlow
38.51
Earnings Yield
0.02
FreeCashFlow Yield
0.03
Market Cap
5,69 Bil.
Enterprise Value
5,56 Bil.
Graham Number
18.84
Graham NetNet
0.23

Income Statement Metrics

Net Income per Share
2.05
Income Quality
1.45
ROE
0.28
Return On Assets
0.14
Return On Capital Employed
0.18
Net Income per EBT
0.73
EBT Per Ebit
1.32
Ebit per Revenue
0.2
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.49
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.42
Operating Profit Margin
0.2
Pretax Profit Margin
0.27
Net Profit Margin
0.2

Dividends

Dividend Yield
0.01
Dividend Yield %
0.98
Payout Ratio
0.54
Dividend Per Share
1.1

Operating Metrics

Operating Cashflow per Share
2.98
Free CashFlow per Share
2.83
Capex to Operating CashFlow
0.05
Capex to Revenue
0.01
Capex to Depreciation
0.82
Return on Invested Capital
0.18
Return on Tangible Assets
0.15
Days Sales Outstanding
111.76
Days Payables Outstanding
25.82
Days of Inventory on Hand
0
Receivables Turnover
3.27
Payables Turnover
14.14
Inventory Turnover
316898000
Capex per Share
0.15

Balance Sheet

Cash per Share
3,98
Book Value per Share
7,69
Tangible Book Value per Share
7.52
Shareholders Equity per Share
7.69
Interest Debt per Share
1.47
Debt to Equity
0.19
Debt to Assets
0.11
Net Debt to EBITDA
-1.02
Current Ratio
2.97
Tangible Asset Value
0,38 Bil.
Net Current Asset Value
0,08 Bil.
Invested Capital
412691000
Working Capital
0,26 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,16 Bil.
Average Payables
0,02 Bil.
Average Inventory
1
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Exponent, Inc. Dividends
Year Dividends Growth
2013 1
2014 1 100%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 1 100%
2024 1 0%

Exponent, Inc. Profile

About Exponent, Inc.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

CEO
Dr. Catherine Ford Corrigan P.
Employee
949
Address
149 Commonwealth Drive
Menlo Park, 94025

Exponent, Inc. Executives & BODs

Exponent, Inc. Executives & BODs
# Name Age
1 Dr. Bernard Ross P.E., Ph.D.
Co-Founder, Chairman Emeritus & Principal Engineer
70
2 Dr. Subbaiah V. Malladi P.E., Ph.D.
Chief Technology Officer & Principal Engineer
70
3 Mr. Brian Kundert
Chief Human Resources Officer
70
4 Joseph Sala
Group Vice President
70
5 Mr. Richard L. Schlenker Jr.
Executive Vice President, Chief Financial Officer & Corporate Secretary
70
6 Ms. Gina Flynn
Vice President of Legal & General Counsel
70
7 Dr. Catherine Ford Corrigan P.E., Ph.D.
President, Chief Executive Officer & Director
70
8 Mr. Eric R. Anderson
Vice President of Finance & Accounting
70
9 Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D.
Group Vice President
70
10 Dr. Joseph Rakow Ph.D.
Group Vice President
70

Exponent, Inc. Competitors